scholarly article | Q13442814 |
P50 | author | Scott D. Grosse | Q47698025 |
Mary M Hulihan | Q115088548 | ||
P2093 | author name string | Sheree L Boulet | |
Marie E Faughnan | |||
Althea M Grant | |||
P2860 | cites work | Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis | Q28236856 |
The accuracy of discharge diagnosis coding for Amyotrophic Lateral Sclerosis in a large teaching hospital | Q33491038 | ||
Administrative data sets and health services research on hemoglobinopathies: a review of the literature. | Q33544936 | ||
Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). | Q33897059 | ||
Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. | Q33962399 | ||
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. | Q34018196 | ||
Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment | Q34024081 | ||
Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia | Q35194662 | ||
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study | Q36281641 | ||
Brain arteriovenous malformation multiplicity predicts the diagnosis of hereditary hemorrhagic telangiectasia: quantitative assessment | Q37055681 | ||
Health care utilization and expenditures for children and young adults with muscular dystrophy in a privately insured population | Q37134991 | ||
Embolization for pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia: a decision analysis | Q37450493 | ||
Prevalence and nature of dyspnea in patients with hereditary hemorrhagic telangiectasia (HHT). | Q38458863 | ||
Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients | Q40819926 | ||
Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. | Q43146590 | ||
Sickle cell disease-related pediatric medical expenditures in the U.S. | Q45130084 | ||
Cost savings through molecular diagnosis for hereditary hemorrhagic telangiectasia | Q45130977 | ||
Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population. | Q46012391 | ||
Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan | Q48323777 | ||
A public health framework for rare blood disorders. | Q51846582 | ||
Molecular diagnosis in hereditary hemorrhagic telangiectasia: findings in a series tested simultaneously by sequencing and deletion/duplication analysis. | Q54626589 | ||
Hereditary hemorrhagic telangiectasia | Q72039760 | ||
Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations | Q82522372 | ||
Life expectancy in patients with hereditary haemorrhagic telangiectasia | Q83089623 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hereditary hemorrhagic telangiectasia | Q776881 |
P304 | page(s) | 33-39 | |
P577 | publication date | 2013-05-23 | |
P1433 | published in | Genetics in Medicine | Q15765508 |
P1476 | title | The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia | |
P478 | volume | 16 |
Q57094665 | A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers |
Q64991935 | Age-appropriate compliance and completion of up to five doses of pertussis vaccine in US children. |
Q38662338 | Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions. |
Q64109023 | Assessing the Hereditary Hemorrhagic Telangiectasia Algorithms in a Community-Based Patient Population |
Q35611660 | Complications and mortality in hereditary hemorrhagic telangiectasia: A population-based study. |
Q99560535 | Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial |
Q30936606 | Enrollment factors and bias of disease prevalence estimates in administrative claims data |
Q47789552 | Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature |
Q87183482 | Gender differences in hereditary hemorrhagic telangiectasia severity |
Q33563773 | Health screening behaviors among adults with hereditary hemorrhagic telangiectasia in North America |
Q90644032 | Hereditary Hemorrhagic Telangiectasia: A Rare Cause of Anemia |
Q40663295 | High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States |
Q64124891 | Histoplasmosis-related healthcare use, diagnosis, and treatment in a commercially insured population, United States |
Q55001675 | Impact of Age on Outcomes in Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia. |
Q95319248 | Japanese encephalitis vaccination in pregnancy among U.S. active duty military women |
Q36825835 | Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia |
Q90451889 | Life-threatening Anaemia in Patient with Hereditary Haemorrhagic Telangiectasia (Rendu-Osler-Weber Syndrome) |
Q36057008 | Meeting the emerging public health needs of persons with blood disorders |
Q57193278 | Modeling Heterogeneity in Healthcare Utilization Using Massive Medical Claims Data |
Q34388065 | Optimal management of hereditary hemorrhagic telangiectasia |
Q89538765 | Potential Undiagnosed VWD Or Other Mucocutaneous Bleeding Disorder Cases Estimated From Private Medical Insurance Claims |
Q34462802 | Targeting under-diagnosis in hereditary hemorrhagic telangiectasia: a model approach for rare diseases? |
Q33715614 | The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort |
Q57488655 | Thyroplasty in unilateral vocal fold paresis with coexisting hereditary hemorrhagic telenagiectasia: A case report |
Q49826259 | Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia |